Neostigmine Methylsulfate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Neostigmine Methylsulfate drug offered from Fresenius Kabi USA, LLC. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | Neostigmine Methylsulfate |
SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-01-08 |
END MARKETING DATE: | 0000-00-00 |
Neostigmine Methylsulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Neostigmine Methylsulfate from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/mL) |
START MARKETING DATE: | 2015-01-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-413_6448229c-e650-47ba-bb00-cba3604502c5 |
PRODUCT NDC: | 63323-413 |
APPLICATION NUMBER: | NDA203629 |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers: